Open AccessCombining Induced Pluripotent Stem Cell with Next Generation Sequencing Technology to Gain New Insights into Pathobiology and Treatment of Pulmonary Arterial Hypertension
Author(s) -
Rabinovitch Marlene
Publication year - 2013
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.4103/2045-8932.109963
Subject(s) - medicine , induced pluripotent stem cell , pulmonary hypertension , stem cell , cardiology , bioinformatics , computational biology , embryonic stem cell , microbiology and biotechnology , genetics , gene , biology
It was an honor to give the Giles F. Filley Lecture. Dr. Filley was cofounder of the Aspen Lung Conference and a master clinician and scientist with major contributions to the field of acid base balance. He developed “caribicarb,” a combination of calcium carbonate and sodium bicoarbonate. He also contributed to our understanding of the pathophysiology of chronic obstructive pulmonary disease and emphysema through his many publications including one in which he described the elastic properties of the different lobes of the human lung.[1]